133 related articles for article (PubMed ID: 1660386)
1. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma.
Balaban EP; Walker BS; Cox JV; Sein AA; Abrams PG; Salk D; Sheehan RG; Frenkel EP
Clin Nucl Med; 1991 Oct; 16(10):732-6. PubMed ID: 1660386
[TBL] [Abstract][Full Text] [Related]
2. Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard staging methods.
Balaban EP; Walker BS; Cox JV; Bordlee RP; Salk D; Abrams PG; Sheehan RG; Frenkel EP
Clin Nucl Med; 1992 Jun; 17(6):439-45. PubMed ID: 1319861
[TBL] [Abstract][Full Text] [Related]
3. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody.
Vansant JP; Johnson DH; O'Donnell DM; Stewart JR; Sonin AH; McCook BM; Powers TA; Salk DJ; Frist WH; Sandler MP
Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphy with nanocolloid Tc 99m in patients with small cell lung cancer, with special reference to bone marrow and hepatic metastasis.
Widding A; Stilbo I; Hansen SW; Hansen HH; Rossing N
Eur J Nucl Med; 1990; 16(8-10):717-9. PubMed ID: 2166669
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
Zoeller G; Sandrock D; Munz DL; Ringert RH
Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
[TBL] [Abstract][Full Text] [Related]
7. The value of the bone scan and bone marrow biopsy staging small cell lung cancer.
Levitan N; Byrne RE; Bromer RH; Faling LJ; Caslowitz P; Pattern DH; Hong WK
Cancer; 1985 Aug; 56(3):652-4. PubMed ID: 2988751
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow scintigraphy in small cell carcinoma of the lung.
Li DJ; Maughan TS; Miles KA; Wraight EP
Nucl Med Commun; 1994 Jan; 15(1):29-33. PubMed ID: 8152690
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases.
Reske S; Kartsens J; Sohn M; Glöckner W; Buell U
Acta Oncol; 1993; 32(7-8):753-61. PubMed ID: 8305223
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY; Papoff W
Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
[TBL] [Abstract][Full Text] [Related]
15. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
Duncker CM; Carrió I; Berná L; Estorch M; Alonso C; Ojeda B; Blanco R; Germá JR; Ortega V
J Nucl Med; 1990 Sep; 31(9):1450-5. PubMed ID: 2168473
[TBL] [Abstract][Full Text] [Related]
16. Imaging lung cancer with radiolabeled antibodies.
Breitz HB; Sullivan K; Nelp WB
Semin Nucl Med; 1993 Apr; 23(2):127-32. PubMed ID: 8390098
[TBL] [Abstract][Full Text] [Related]
17. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
18. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
Levenson RM; Sauerbrunn BJ; Ihde DC; Bunn PA; Cohen MH; Minna JD
AJR Am J Roentgenol; 1981 Jul; 137(1):31-5. PubMed ID: 6264774
[TBL] [Abstract][Full Text] [Related]
19. [Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow].
Reske SN; Karstens JH; Henrich MM; Sohn M; Glöckner W; Jakse G; Büll U
Nuklearmedizin; 1993 Jun; 32(3):111-9. PubMed ID: 8327329
[TBL] [Abstract][Full Text] [Related]
20. Discrepant uptake between 111In-pentetreotide and 99mTc-MDP in bone metastases of small-cell lung cancer.
Meristoudis G; Ilias I; Giannakopoulos V; Batsakis C; Christakopoulou J
Hell J Nucl Med; 2009; 12(3):283-4. PubMed ID: 19936347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
